Home›Screener›TOVX›Profile
D
49/100

Theriva Biologics, Inc.

TOVXBiotech / Pharma
← Signals View
Analyst Summary
✓ VERIFIED2026-06-17

Theriva Biologics, Inc. (TOVX) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 1 Phase 1[2].

No Form 4 insider filings for TOVX were recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-06-17) ↗
  2. ClinicalTrials.gov (2026-06-17) ↗
  3. ClinicalTrials.gov (2026-06-17) ↗
  4. SEC EDGAR · 0000894158 (2026-06-17) ↗
Clinical Trials
1
NCT04692181Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant, Prevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
Source ↗
clinicaltrials_gov · Retrieved 2026-06-17
Insider Activity
1
0 filings
Source ↗
sec_edgar · Retrieved 2026-06-17
Not financial advice. BiotechSign profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-202026-07-17
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Biotech / Pharma)
GRIGRI Bio, Inc.
A
RNACCartesian Therapeutics, Inc.
B
VRDNViridian Therapeutics, Inc.
C
JAZZJazz Pharmaceuticals plc
C
CMPXCompass Therapeutics, Inc.
C
Data Provenance
cik1 verified
clinical trial1 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR